March 26, 2021—We are currently overweight emerging markets equities—including Chinese equities. Four pillars support our position. First is our view that the vaccines have prompted a cyclical rally that is, in general, constructive for global equities. Second, we believe emerging markets will see faster economic growth than developed markets. Third, the Asia ex-Japan region, including China, has so far successfully managed the COVID-19 crisis, in our opinion.
March 19, 2021—All’s quiet (for now) on the inflationary front. While we project a lift in the next few months, take it with a grain of salt, as the year-over-year comparison is to a pandemic-induced economic shutdown. Down the road, we anticipate higher inflation approaching 3%, but risk is to the upside—as we expect an improving economy and a largely vaccinated nation back in stores, with money in their pockets.
March 16, 2021—Inflation is on the minds and lips of everyone these days, and the just-signed stimulus package is increasing those concerns. Vaccine deployment is picking up, COVID-19 cases are down, spending is accelerating, and the nation is clamoring to enjoy the outdoors and one another in a way we haven’t in a full year. With the passage and signing of the American Rescue Plan Act of 2021 (ARPA) last week, we have growing conviction of strong economic growth in 2021.
